CTRI/2024/03/064861
Not yet recruiting
未知
A comparative study to evaluate the efficacy and safety of twice daily versus alternate day oral iron therapy in treatment of mild to moderate iron deficiency anemia in adults - an open label, randomized controlled study - NI
Viswanathan S0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Viswanathan S
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient willing to give written informed consent and willing to come for follow\-up
- •2\. Adults 18\-60 years of age of either sex
- •3\. Patients newly diagnosed as mild to moderate iron deficiency anemia by WHO guidelines
Exclusion Criteria
- •1\. Patients having comorbidities like chronic kidney disease, chronic liver disease, severe anemia requiring blood transfusion/parenteral iron therapy, cardiac failure patients, gastrointestinal abnormalities, menstrual abnormalities, malignancies and HIV
- •2\. Pregnant and Lactating mothers
- •3\. Patients with clinical or laboratory evidence of other causes of anemia like hemolytic anemias, hemoglobinopathies, gastrointestinal bleed, iron malabsorption, megaloblastic anemia, or anemia of chronic disease
- •4\.Patients with hypersensitivity and intolerance to oral iron supplements.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Efficacy of oral tranexamic acid and topical triple combination cream in treatment of melasmaHealth Condition 1: L814- Other melanin hyperpigmentationCTRI/2024/04/065382MOHAN H
Not yet recruiting
Not Applicable
Comparison of efficacy and safety of Vortioxetine and Escitalopram in depressive patients.Health Condition 1: F321- Major depressive disorder, singleepisode, moderateCTRI/2023/12/060661Ronakkumar Chandubhai Patel
Not yet recruiting
Not Applicable
A study to compare two drugs Seratconazole versus Luliconacole for improvement of symptoms and to compare the side effectsHealth Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2022/10/046157Yuvarani R
Not yet recruiting
Not Applicable
Comparison study to evaluate the efficacy and safety of a topical gelCTRI/2024/08/072002Abbott India Limited
Not yet recruiting
Not Applicable
Safety and effectiveness of rosuvastatin versus rosuvastatin with fenofibrate in patients with dyslipidemia.Health Condition 1: E785- Hyperlipidemia, unspecifiedCTRI/2024/07/070696Dr Shivam Yadav